It does not add peptide identity, purity, or activity to any material
Patients should maintain open communication with their healthcare team about challenges, side effects, and goals
In in-vitro and experimental research models, CJC-1295 without DAC is primarily used to analyze peptidereceptor interactions, intracellular signaling mechanisms, and growth-related biochemical processes
However, despite previous reports on the potential advantage posed by GLP1-based multi-agonists in the management of obesity and metabolic disease, as recently exemplified by the dramatic body weight-lowering actions of the GLP1/GIP dual agonist, tirzepatide 47 , to our knowledge, no study has addressed to date the pharmacological characterization of GLP1-based unimolecular multi-agonists for management of reproductive and metabolic alterations of PCOS, using suitable preclinical models, as pre-requisite for their application in clinics
Population-Specific Effects : Imcivree is specifically designed for individuals with obesity due to conditions such as POMC, PCSK1, or LEPR deficiencies
doi: 10.3390/biom5020545